In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 1, 1999, Pages 65-70

  Barchiesi, Francesco ^a   Gallo, Domenico ^a   Caselli, Francesca ^a   Falconi Di Francesco, Luigi ^a   Arzeni, Daniela ^a   Giacometti, Andrea ^a   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCYTOSINE; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFICACY; DRUG INTERACTION; DRUG POTENTIATION; DRUG RESISTANCE; IN VITRO STUDY; TREATMENT FAILURE;

ANTIFUNGAL AGENTS; COLONY COUNT, MICROBIAL; CRYPTOCOCCUS NEOFORMANS; DRUG INTERACTIONS; DRUG SYNERGISM; FLUCYTOSINE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS;

EID: 0032837826     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.1.65     Document Type: Article

References (23)

1. Mitchell, T. G. & Perfect, J. R. (1995). Cryptococcosis in the era of AIDS - 100 years after discovery of Cryptococcus neoformans. Clinical Microbiology Reviews 8, 515-48.
2. Zuger, A., Louie, E., Holzman, R. S., Simberkoff, M. S. & Rahal, J. J. (1986). Cryptococcal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Annals Internal Medicine 104, 234-40.
3. Bennett, J. E., Dismukes, W. E., Duma, R. J., Medoff, G., Sande, M. A., Gallis, H. et al. (1979). A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. New England Journal of Medicine 301, 126-31.
4. Allendoerfer, R., Marquis, A. J., Rinaldi, M. G. & Graybill, J. R. (1991). Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis. Antimicrobial Agents and Chemotherapy 35, 726-9.
5. Ding, J. C., Bauer, M., Diamond, D. M., Leal, M. A. E., Johnson, D., Williams, B. K. et al. (1997). Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis. Antimicrobial Agents and Chemotherapy 41, 1589-93.
6. Franzot, S. P. & Casadevall, A. (1997). Pneumocandin L-743,872 enhances the activity of amphotericin B and fluconazole against Cryptococcus neoformans in vitro. Antimicrobial Agents and Chemotherapy 41, 331-6.
7. Iovanitti, C., Negroni, R., Bava, J., Finquelievich, J. & Kral, M. (1995). Itraconazole and flucytosine plus itraconazole combination in the treatment of experimental cryptococcosis in hamsters. Mycoses 38, 449-52.
8. Larsen, R. A., Bauer, M., Weiner, J. M., Diamond, D. M., Leal, M. E., Ding, J. C. et al. (1996). Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis. Antimicrobial Agents and Chemotherapy 40, 2178-82.
9. Larsen, R. A., Bozzette, S. A., Jones, B. E., Haghighat, D., Leal, M. A., Forthal, D. et al. (1994). Fluconazole combined with flucytosine for the treatment of cryptococcal meningitis in patients with AIDS. Clinical Infectious Diseases 19, 741-5.
10. Nguyen, M. H., Barchiesi, F., McGough, D. A., Yu, V. L. & Rinaldi, M. G. (1995). In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans. Antimicrobial Agents and Chemotherapy 39, 1691-5.
11. Nguyen, M. H., Najvar, L. K., Yu, C. Y. & Graybill, J. R. (1997). Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis. Antimicrobial Agents and Chemotherapy 41, 1120-3.
12. Perfect, J. R. & Durak, D. T. (1982). Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole. Journal of Infectious Diseases 146, 429-35.
13. Polak, A. (1987). Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. Chemotherapy 33, 381-95.
14. Van-Custem, J. (1993). Therapy of experimental meningeal and disseminated cryptococcosis. Mycoses 36, 357-67.
15. National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts - Approved Standard: M27-A. NCCLS, Villanova, PA.
16. Barchiesi, F., Falconi Di Francesco, L., Compagnucci, P., Arzeni, D., Giacometti, A. & Scalise, G. (1998). In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. Journal of Antimicrobial Chemotherapy 41, 59-65.
17. Barchiesi, F., Falconi Di Francesco, L. & Scalise, G. (1997). In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles. Antimicrobial Agents and Chemotherapy 41, 1812-4.
18. Moellering, R. C. (1995). Principles of anti-infective therapy. In Principles and Practice of Infectious Diseases, (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 199-211. Churchill Livingstone, Edinburgh, UK.
19. Sugar, A. (1995). Use of amphotericin B with azole antifungal drugs: what are we doing? Antimicrobial Agents and Chemotherapy 39, 1907-12.
20. Edelstein, H. (1994). Increased fluconazole resistance of Cryptococcus neoformans isolated from a patients with AIDS and recurrent meningitis. Clinical Infectious Diseases 19, 975-6.
21. Como, J. A. & Dismukes, W. E. (1994). Oral azole drugs as systemic antifungal therapy. New England Journal of Medicine 330, 263-72.
22. Prentice, A. G., Warnock, D., Johnson, S. A. N., Phillips, M. J. & Oliver, D. A. (1994). Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients. Journal of Antimicrobial Chemotherapy 34, 247-52.
23. Klepser, M. E., Wolfe, E. J. & Pfaller, M. A. (1998). Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans. Journal of Antimicrobial Chemotherapy 41, 397-401.